about
Social outcomes in young adult survivors of low incidence childhood cancersRisk of cancer among children of cancer patients - a nationwide study in FinlandHepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.Infectious exposure in the first years of life and risk of central nervous system tumours in children: analysis of birth order, childcare attendance and seasonality of birth.Preterm delivery among female survivors of childhood, adolescent and young adulthood cancerActive video games to promote physical activity in children with cancer: a randomized clinical trial with follow-up.The siblings of childhood cancer patients need early support: a follow up study over the first year.Late morbidity in long-term survivors of childhood brain tumors: a nationwide registry-based study in FinlandThe use of next generation sequencing technology to study the effect of radiation therapy on mitochondrial DNA mutation.Late new morbidity in survivors of adolescent and young-adulthood brain tumors in Finland: a registry-based study.Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome.Probability of parenthood after early onset cancer: a population-based study.Stillbirth, early death and neonatal morbidity among offspring of female cancer survivorsCompulsory military service as a measure of later physical and cognitive performance in male survivors of childhood cancer.Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma.Non-graduation after comprehensive school, and early retirement but not unemployment are prominent in childhood cancer survivors-a Finnish registry-based study.Leukemic blasts are present at low levels in spinal fluid in one-third of childhood acute lymphoblastic leukemia cases.Use of endocrinological and neurological medication among 5-year survivors of young onset brain tumors.Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility.Fatigue in young survivors of extracranial childhood cancer: a Finnish nationwide survey.Opinions on childhood cancer care and degree of agreement between patient/mother and mother/father pairs.Evaluation of the effects of different transfusion trigger levels during the treatment of childhood acute lymphoblastic leukemia.The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL-92 and ALL-2000 protocols.Home-Based Exercise Training Improves Left Ventricle Diastolic Function in Survivors of Childhood ALL: A Tissue Doppler and Velocity Vector Imaging Study.Cardiovascular medication after cancer at a young age in Finland: A nationwide registry linkage study.Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland.Late psychiatric morbidity in survivors of cancer at a young age: a nationwide registry-based study.Decreased spermatogonial quantity in prepubertal boys with leukaemia treated with alkylating agentsLate mortality among 5-year survivors of early onset cancer: a population-based register study.Potential gonadotoxicity of treatment in relation to quality of life and mental well-being of male survivors of childhood acute lymphoblastic leukemia.Fetal growth, preterm birth, neonatal stress and risk for CNS tumors in children: a Nordic population- and register-based case-control study.Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based case-control study.Outcome of single fraction total body irradiation-conditioned stem cell transplantation in younger children with malignant disease--comparison with a busulphan-cyclophosphamide regimen.High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies.Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland.Hypothyroidism among pediatric cancer patients: a nationwide, registry-based study.Treatment-related mortality in relapsed childhood acute lymphoblastic leukemia.Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe.Bone mineral density is compromised in very long-term survivors of irradiated childhood brain tumor.Quality of life and late-effects among childhood brain tumor survivors: a mixed method analysis.
P50
Q29305178-5D549C66-80C1-4B54-889B-F9F3B423EDCAQ30476639-B350DC55-E177-4873-ACFD-FCD28E0FFF61Q33441148-52A526F8-18F3-49AD-8533-8A5E6B1365E4Q33903717-FC824C3F-843F-4FA6-A419-C691E141CB0EQ34057897-9352918C-1C05-468A-941D-BAE517C73867Q35141325-A84DF327-CF29-4EFC-AC0B-C531364640EFQ35277499-362115C8-19D7-4191-8D90-441C1EEC6AAAQ35788606-62BDB75A-93BA-4B7A-B308-1E694DADD191Q35968154-2A5CD8A9-5FFC-4E34-94F4-CCD8D97D466CQ36082513-8B5AA840-1092-4384-8169-F4CF7F88C7A5Q36420748-5BA173F3-7AC3-4C14-86C5-E55F7C66A6FCQ37313748-DB23AA02-B1D3-439C-822D-FA601CB2481BQ37398376-978C360F-DE1F-4222-B1E4-2FD927B8F881Q38677016-CE6FE455-04F8-40DF-BE58-D940926B615AQ39217689-D2D976F6-403E-4759-AD1E-4E9C56477EE7Q39313862-54D1F93F-4A3F-4FF9-A040-8F438CBD2C9AQ39571116-CCA24629-4D9E-4C03-A051-3D25334F4D23Q39820896-A86AC17C-9B15-4996-A198-2241FB8D8556Q39992776-FB8DE87B-65A0-4B11-BEDC-E601C0DE946CQ40004870-0008E50D-B6BC-4CB1-8784-F2FF7A4BEFC9Q40136868-491B372E-4864-4507-AF22-418CB95A4819Q40380618-68423400-9162-46EB-B8A1-603D3EDF8552Q40539062-2759E6AF-0EDA-41DB-8DD0-CC38F7364F9AQ40745163-877FE93C-6EFD-4033-840D-88F997AA9CB5Q41094773-0F4CD180-3EF7-4045-9E96-4BF29544FA4EQ41363389-2C9427FA-4C31-4E57-9664-571E561D309CQ41755672-EB419DCA-D1F7-4593-AA3C-8D308237BF03Q41843769-0333B43B-485D-4F93-9383-6F72E380225AQ42202408-730292FE-8143-435F-BECD-AE409916CB18Q43670269-D5C289C9-9D66-4B84-974B-3F5434F03E77Q44023489-32AED884-16BA-438D-A8D4-A821F3D187E1Q44782576-0EC83AB2-6AF6-46F7-9755-E4192E77209CQ44910545-9CD7E0DD-3FB7-41F5-B625-167CA780F8CCQ45126324-8CFE0282-1EA9-4FC5-B3A3-05F2188EEF23Q45855530-E29C6D83-008D-4D90-A4B8-6199C7F59E59Q46853461-8987959E-FFEC-4099-B2C8-545BFA1F0854Q47566809-44198E77-B544-4F1F-9FA9-1CCC46F31959Q47676704-9CA12DA2-D906-490D-828B-1F25633E04F7Q47836874-3AA6154F-8666-4A44-84D9-B14350958426Q47948711-6AA8D3FB-BBCC-416D-9413-5519E1A0F5CA
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Päivi Lähteenmäki
@ast
Päivi Lähteenmäki
@en
Päivi Lähteenmäki
@es
Päivi Lähteenmäki
@nl
Päivi Lähteenmäki
@sl
type
label
Päivi Lähteenmäki
@ast
Päivi Lähteenmäki
@en
Päivi Lähteenmäki
@es
Päivi Lähteenmäki
@nl
Päivi Lähteenmäki
@sl
altLabel
Päivi Lähteenmäki
@en
prefLabel
Päivi Lähteenmäki
@ast
Päivi Lähteenmäki
@en
Päivi Lähteenmäki
@es
Päivi Lähteenmäki
@nl
Päivi Lähteenmäki
@sl
P106
P1153
7007064778
P21
P31
P496
0000-0002-5500-9606